Mapmygenome cements global leadership in Genomics with strategic acquisition of Canada's Microbiome Insights
Having supported over 600 global clients with 1,000+ cutting-edge microbiome studies, Microbiome Insights is a leading partner for academic, clinical, and industry researchers. Its founders, Dr. Brett Finlay, Dr. William Mohn, and Malcolm Kendall, are recognized global experts.
Microbiome Insights will maintain its role as a premier CRO, empowering global research. Simultaneously, Mapmygenome will introduce its integrated genomics and microbiome testing services to North America, making holistic, data-driven health solutions more accessible.
"The human microbiome is pivotal to health, and this acquisition positions us as a leader in this area. We gain exceptional expertise in metagenomics, transcriptomics, and targeted metabolomics to serve academic, biotech, and clinical sectors," declared Anu Acharya, Founder and CEO of Mapmygenome. "This accelerates our North American footprint aligning with our strategic vision of growth through targeted acquisitions leading up to our listing on the Indian market later this year"
"Joining forces with Mapmygenome, provides the resources and capabilities to offer higher quality services to our clients and accelerate growth. The combination of their expertise in AI-driven genomics solutions and our deep microbiome expertise will result in a new standard of cutting-edge services for clients worldwide," said Malcolm Kendall, CEO of Microbiome Insights.
Financial terms were not disclosed.
About Mapmygenome:
Founded a decade ago, we are a leading genomics company driven by pioneering research and a vision for preventive healthcare. We harness AI-driven genomic and microbiome testing to deliver personalized health solutions, with offerings like at-home DNA tests for proactive health and longevity. For healthcare providers, our diagnostic genomic tests are conducted in a CAP-accredited lab, ensuring high accuracy, complemented by genetic counseling.
About Microbiome Insights:
We are a global leader providing end-to-end microbiome sequencing and comprehensive bioinformatic analysis. Collaborating with pharma, biotech, nutrition, cosmetic, and agriculture clients, alongside leading academic and government institutions, we've supported over 1,000 studies, from basic research to clinical trials, and biomarker discovery to machine-learning based modeling.
Photo: https://mma.prnewswire.com/media/2698768/Mapmygenome.jpgLogo: https://mma.prnewswire.com/media/2698769/Mapmygenome_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/in/news-releases/mapmygenome-cements-global-leadership-in-genomics-with-strategic-acquisition-of-canadas-microbiome-insights-302468148.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Taiwan's "Star Hotel" and "Taiwan Host B&B" Brands Make Their Debut at 2025 NATAS Holidays Travel Fair in Singapore
TAIPEI, Aug. 14, 2025 /PRNewswire/ -- Taiwan's two official accommodation brands—Taiwan Host B&B and Star Hotel, are making their first appearance at the 2025 NATAS Holidays Travel Fair, holding from August 15–17 at Singapore EXPO Hall 5. Showcasing the warmth of Taiwanese hospitality, the Taiwan Pavilion will offer a range of engaging activities including Taiwan Host B&B ambassador sharing sessions, travel trivia challenges, and social media check-in prize draws. Visitors will also have the exciting opportunity to win a free round-trip flight between Singapore and Taiwan. This news comes from Staynews. Taiwan Host B&B is an official certification program promoting homestays that uphold six core values: friendliness, warmth, cleanliness, hygiene, safety, and quality service. These certified B&Bs offer travelers a high level of service and a comfortable accommodation experience. To date, there are over 1,900 Taiwan Host B&Bs across Taiwan. Among them, 100 "Golden-Award Taiwan Host B&Bs" have been carefully selected and categorized into five themes—Nature & Ecology, Cultural Discovery, Architectural Charm, Family & Pet Travel, and Culinary Delights—designed to meet the diverse travel interests of international visitors. Star Hotels represent another official accommodation brand from Taiwan, selected through a rigorous evaluation process by mystery inspectors who assess over 500 items across both hardware and service. Hotels are ranked from 1 to 3 stars (basic, budget, and comfort) to 4 and 5 stars (deluxe and premium), with a special "5-Star Excellence" level for top-tier properties. There are currently nearly 200 government-certified Star Hotels in Taiwan. These hotels serve as a trusted guide for travelers, providing assurance in both facilities and service quality. A special highlight at the pavilion will be sharing sessions by Golden-Award Taiwan Host B&B ambassadors, who will introduce the unique charms of homestays across Taiwan, covering themes such as nature experiences, cultural immersion, and family/pet-friendly stays. A B&B owner from Kinmen will also host a demonstration of the Mid-Autumn Festival dice game "Bo Bing", along with free tastings of Kinmen's signature souvenirs like peanut brittle and mini pastries, offering Singaporean visitors a nostalgic taste of Nanyang flavor and showcasing the deep connection between Taiwan's local culture and overseas heritage. Visitors who join guided tours of the Taiwan Host B&B and Star Hotel booths and complete a short questionnaire will receive a free bilingual handbook featuring the Golden-Award Taiwan Host B&Bs, along with the chance to take home limited-edition gifts. This appearance at the NATAS Holidays Travel Fair is a milestone in the international outreach of Taiwan's accommodation brands, offering travelers in Singapore a first-hand look at Taiwan's heartfelt hospitality and the character of its accommodation experiences. For more information about Taiwan Host B&Bs and Star Hotels, please visit: (Press release from Staynews : View original content to download multimedia: SOURCE StayNews
Business Upturn
2 hours ago
- Business Upturn
Nomura reiterates buy on Infosys, sets Rs 1,880 target price after Australian carve-out deal with Telstra
By Markets Desk Published on August 14, 2025, 07:58 IST Nomura has reiterated its buy call on Infosys with a target price of ₹1,880 after the company announced a carve-out deal in Australia with Telstra. Under the agreement, Infosys will acquire a 75% stake and operational control in a newly created entity, while Telstra will retain the remaining 25%. The Indian IT major will pay AUD 233 million for its stake. Nomura estimates the acquisition will add around $70 million to Infosys' revenue in FY26, contributing approximately 35 basis points to overall growth. The brokerage views the deal as a strategic expansion of Infosys' capabilities and client reach in the Australian market, further strengthening its partnership with Telstra. The brokerage believes the move aligns with Infosys' focus on targeted acquisitions to drive geographic and sectoral growth, and with the company's solid balance sheet, it sees scope for further such transactions to enhance long-term earnings visibility. Disclaimer: The views and recommendations made in this article are those of Nomura. This article does not constitute investment advice. Investors should consult their financial advisors before making any investment decisions. Ahmedabad Plane Crash Markets Desk at
Business Upturn
2 hours ago
- Business Upturn
Morgan Stanley keeps overweight on Jubilant FoodWorks, sees growth momentum supporting margins
By Markets Desk Published on August 14, 2025, 07:53 IST Morgan Stanley has reiterated its overweight rating on Jubilant FoodWorks with a target price of ₹781, highlighting strong growth momentum in its Indian business and expectations of margin improvement ahead. The company reported an 18% year-on-year rise in revenue for the first quarter, with Domino's India like-for-like growth at 11.6%, outpacing its quick service restaurant peers. The brokerage said the company remains focused on market penetration while maintaining limited price hikes, a strategy it believes will sustain healthy volume-led growth despite the high base of previous years. Management expects gross margins to improve as cost pressures ease, with top-line growth helping to support EBITDA margin expansion over time. Morgan Stanley sees Jubilant FoodWorks well positioned to capitalise on strong brand equity and consumer demand trends, reinforcing its positive stance on the stock. Disclaimer: The views and recommendations made in this article are those of Morgan Stanley. This article does not constitute investment advice. Investors should consult their financial advisors before making any investment decisions. Ahmedabad Plane Crash Markets Desk at
